Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna G Sorace

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Mathematical Biosciences and Engineering : MBE|December 5, 2023
Predicting response to combination evofosfamide and immunotherapy under hypoxic conditions in murine models of colon cancerErnesto A B F Lima, Patrick N Song, Kirsten Reeves, et al.
Pharmaceutics|May 27, 2026
SAHA Alters Macrophages in the Tumor-Immune Landscape in Preclinical Models of Triple-Negative Breast CancerShannon E Lynch, Corinne I Crawford, Troy D Randall, et al.
Molecular Imaging and Biology|August 11, 2016
Quantitative [<sup>18</sup>F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast CancerAnna G Sorace, Anum K Syed, Stephanie L Barnes, et al.
Translational Oncology|December 16, 2014
Evaluating treatment response using DW-MRI and DCE-MRI in trastuzumab responsive and resistant HER2-overexpressing human breast cancer xenograftsJennifer G Whisenant, Anna G Sorace, J Oliver McIntyre, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Modeling tumor dynamics and predicting response to chemo-, targeted-, and immune-therapies in a murine model of pancreatic cancerKrithik Vishwanath, Hoon Choi, Mamta Gupta, et al.
Cancer Cell International|December 9, 2020
CD4 T-cell immune stimulation of HER2 + breast cancer cells alters response to trastuzumab in vitroPatrick N Song, Ameer Mansur, Kari J Dugger, et al.
NPJ Systems Biology and Applications|November 4, 2025
Modeling tumor dynamics and predicting response to therapies in a murine pancreatic cancer modelKrithik Vishwanath, Hoon Choi, Mamta Gupta, et al.
BMC Cancer|April 30, 2020
Anti-HER2 induced myeloid cell alterations correspond with increasing vascular maturation in a murine model of HER2+ breast cancerMeghan J Bloom, Angela M Jarrett, Todd A Triplett, et al.
Cancers|March 28, 2026
Characterization of HER2-Positive Murine Breast Cancer Models for Investigating HER2-Targeted Therapy and ImmunotherapyYun Lu, Benjamin P Lee, Abbigael V Eli, et al.
Nature Reviews. Methods Primers|August 29, 2025
Spatial Multiplexing and OmicsJulienne L Carstens, Santhoshi N Krishnan, Arvind Rao, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Mathematical Biosciences and Engineering : MBE|December 5, 2023
Predicting response to combination evofosfamide and immunotherapy under hypoxic conditions in murine models of colon cancerErnesto A B F Lima, Patrick N Song, Kirsten Reeves, et al.
Pharmaceutics|May 27, 2026
SAHA Alters Macrophages in the Tumor-Immune Landscape in Preclinical Models of Triple-Negative Breast CancerShannon E Lynch, Corinne I Crawford, Troy D Randall, et al.
Molecular Imaging and Biology|August 11, 2016
Quantitative [<sup>18</sup>F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast CancerAnna G Sorace, Anum K Syed, Stephanie L Barnes, et al.
Translational Oncology|December 16, 2014
Evaluating treatment response using DW-MRI and DCE-MRI in trastuzumab responsive and resistant HER2-overexpressing human breast cancer xenograftsJennifer G Whisenant, Anna G Sorace, J Oliver McIntyre, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Modeling tumor dynamics and predicting response to chemo-, targeted-, and immune-therapies in a murine model of pancreatic cancerKrithik Vishwanath, Hoon Choi, Mamta Gupta, et al.
Cancer Cell International|December 9, 2020
CD4 T-cell immune stimulation of HER2 + breast cancer cells alters response to trastuzumab in vitroPatrick N Song, Ameer Mansur, Kari J Dugger, et al.
NPJ Systems Biology and Applications|November 4, 2025
Modeling tumor dynamics and predicting response to therapies in a murine pancreatic cancer modelKrithik Vishwanath, Hoon Choi, Mamta Gupta, et al.
BMC Cancer|April 30, 2020
Anti-HER2 induced myeloid cell alterations correspond with increasing vascular maturation in a murine model of HER2+ breast cancerMeghan J Bloom, Angela M Jarrett, Todd A Triplett, et al.
Cancers|March 28, 2026
Characterization of HER2-Positive Murine Breast Cancer Models for Investigating HER2-Targeted Therapy and ImmunotherapyYun Lu, Benjamin P Lee, Abbigael V Eli, et al.
Nature Reviews. Methods Primers|August 29, 2025
Spatial Multiplexing and OmicsJulienne L Carstens, Santhoshi N Krishnan, Arvind Rao, et al.
Pageof 10